Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,797
archived clinical trials in
Peripheral Vascular Disease

Carotid Plaque Characteristics by MRI in AIM-HIGH (Carotid MRI Substudy)
Carotid Plaque Characteristics by MRI in AIM-HIGH
Status: Enrolling
Updated:  2/7/2018
Kelsey Research Foundation
mi
from
Houston, TX
Carotid Plaque Characteristics by MRI in AIM-HIGH (Carotid MRI Substudy)
Carotid Plaque Characteristics by MRI in AIM-HIGH
Status: Enrolling
Updated: 2/7/2018
Kelsey Research Foundation
mi
from
Houston, TX
Click here to add this to my saved trials
Carotid Plaque Characteristics by MRI in AIM-HIGH (Carotid MRI Substudy)
Carotid Plaque Characteristics by MRI in AIM-HIGH
Status: Enrolling
Updated:  2/7/2018
Methodist Hospital
mi
from
Houston, TX
Carotid Plaque Characteristics by MRI in AIM-HIGH (Carotid MRI Substudy)
Carotid Plaque Characteristics by MRI in AIM-HIGH
Status: Enrolling
Updated: 2/7/2018
Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Carotid Plaque Characteristics by MRI in AIM-HIGH (Carotid MRI Substudy)
Carotid Plaque Characteristics by MRI in AIM-HIGH
Status: Enrolling
Updated:  2/7/2018
Harborview Medical Center
mi
from
Seattle, WA
Carotid Plaque Characteristics by MRI in AIM-HIGH (Carotid MRI Substudy)
Carotid Plaque Characteristics by MRI in AIM-HIGH
Status: Enrolling
Updated: 2/7/2018
Harborview Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Carotid Plaque Characteristics by MRI in AIM-HIGH (Carotid MRI Substudy)
Carotid Plaque Characteristics by MRI in AIM-HIGH
Status: Enrolling
Updated:  2/7/2018
Univ of Washington
mi
from
Seattle, WA
Carotid Plaque Characteristics by MRI in AIM-HIGH (Carotid MRI Substudy)
Carotid Plaque Characteristics by MRI in AIM-HIGH
Status: Enrolling
Updated: 2/7/2018
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Carotid Plaque Characteristics by MRI in AIM-HIGH (Carotid MRI Substudy)
Carotid Plaque Characteristics by MRI in AIM-HIGH
Status: Enrolling
Updated:  2/7/2018
Puget Sound VA Medical Center, Seattle Campus
mi
from
Seattle, WA
Carotid Plaque Characteristics by MRI in AIM-HIGH (Carotid MRI Substudy)
Carotid Plaque Characteristics by MRI in AIM-HIGH
Status: Enrolling
Updated: 2/7/2018
Puget Sound VA Medical Center, Seattle Campus
mi
from
Seattle, WA
Click here to add this to my saved trials
Carotid Plaque Characteristics by MRI in AIM-HIGH (Carotid MRI Substudy)
Carotid Plaque Characteristics by MRI in AIM-HIGH
Status: Enrolling
Updated:  2/7/2018
Heart Health Institute
mi
from
Calgary,
Carotid Plaque Characteristics by MRI in AIM-HIGH (Carotid MRI Substudy)
Carotid Plaque Characteristics by MRI in AIM-HIGH
Status: Enrolling
Updated: 2/7/2018
Heart Health Institute
mi
from
Calgary,
Click here to add this to my saved trials
Improving Medication Safety and CVD Risk Factor Control in Kidney Transplant Recipients
Improving Medication Safety and Cardiovascular Risk Factor Control in Kidney Transplant Recipients
Status: Enrolling
Updated:  2/9/2018
Medical University of South Carolina
mi
from
Charleston, SC
Improving Medication Safety and CVD Risk Factor Control in Kidney Transplant Recipients
Improving Medication Safety and Cardiovascular Risk Factor Control in Kidney Transplant Recipients
Status: Enrolling
Updated: 2/9/2018
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Comparing TR Band to Statseal in Conjunction With TR Band
Radial Hemostasis is Facilitated With a Potassium Ferrate Hemostatic Patch (Statseal): the Randomized Controlled Statseal With TR Band Assessment Trial (STAT)
Status: Enrolling
Updated:  2/10/2018
Veteran Affairs Long Beach
mi
from
Long Beach, CA
Comparing TR Band to Statseal in Conjunction With TR Band
Radial Hemostasis is Facilitated With a Potassium Ferrate Hemostatic Patch (Statseal): the Randomized Controlled Statseal With TR Band Assessment Trial (STAT)
Status: Enrolling
Updated: 2/10/2018
Veteran Affairs Long Beach
mi
from
Long Beach, CA
Click here to add this to my saved trials
Cardiovascular Radiologic and Metabolic Assessment in HIV: An Investigation of Pathophysiology
Cardiovascular Radiologic and Metabolic Assessment in HIV: An Investigation of Pathophysiology
Status: Enrolling
Updated:  2/13/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Cardiovascular Radiologic and Metabolic Assessment in HIV: An Investigation of Pathophysiology
Cardiovascular Radiologic and Metabolic Assessment in HIV: An Investigation of Pathophysiology
Status: Enrolling
Updated: 2/13/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
BNP Pharmacodynamics and Effects on Metabolism in Lean and Obese Subjects
BNP Pharmacodynamics and Effects on Metabolism in Lean and Obese Subjects
Status: Enrolling
Updated:  2/13/2018
Translational Research Institute for Metabolism and Diabetes
mi
from
Orlando, FL
BNP Pharmacodynamics and Effects on Metabolism in Lean and Obese Subjects
BNP Pharmacodynamics and Effects on Metabolism in Lean and Obese Subjects
Status: Enrolling
Updated: 2/13/2018
Translational Research Institute for Metabolism and Diabetes
mi
from
Orlando, FL
Click here to add this to my saved trials
Cardiovascular Disease Risk Factors in Chinese American Immigrants
Chinese American Cardiovascular Health Assessment CHA-CHA
Status: Enrolling
Updated:  2/15/2018
New York Downtown Hospital
mi
from
New York, NY
Cardiovascular Disease Risk Factors in Chinese American Immigrants
Chinese American Cardiovascular Health Assessment CHA-CHA
Status: Enrolling
Updated: 2/15/2018
New York Downtown Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Optimizing Behavioral Health Homes for Adults With Serious Mental Illness
Optimizing Behavioral Health Homes by Focusing on Outcomes That Matter Most for Adults With Serious Mental Illness
Status: Enrolling
Updated:  2/19/2018
Community Care Behavioral Health Organizations
mi
from
Pittsburgh, PA
Optimizing Behavioral Health Homes for Adults With Serious Mental Illness
Optimizing Behavioral Health Homes by Focusing on Outcomes That Matter Most for Adults With Serious Mental Illness
Status: Enrolling
Updated: 2/19/2018
Community Care Behavioral Health Organizations
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Evaluation of WIRION™ EPS in Lower Extremities Arteries
Evaluation of WIRION™ EPS in Lower Extremities Arteries
Status: Enrolling
Updated:  2/19/2018
Unity Point
mi
from
Davenport, IA
Evaluation of WIRION™ EPS in Lower Extremities Arteries
Evaluation of WIRION™ EPS in Lower Extremities Arteries
Status: Enrolling
Updated: 2/19/2018
Unity Point
mi
from
Davenport, IA
Click here to add this to my saved trials
Evaluation of WIRION™ EPS in Lower Extremities Arteries
Evaluation of WIRION™ EPS in Lower Extremities Arteries
Status: Enrolling
Updated:  2/19/2018
Ochsner Clinic
mi
from
New Orleans, LA
Evaluation of WIRION™ EPS in Lower Extremities Arteries
Evaluation of WIRION™ EPS in Lower Extremities Arteries
Status: Enrolling
Updated: 2/19/2018
Ochsner Clinic
mi
from
New Orleans, LA
Click here to add this to my saved trials
Evaluation of WIRION™ EPS in Lower Extremities Arteries
Evaluation of WIRION™ EPS in Lower Extremities Arteries
Status: Enrolling
Updated:  2/19/2018
Columbia-Presbyterian
mi
from
New York, NY
Evaluation of WIRION™ EPS in Lower Extremities Arteries
Evaluation of WIRION™ EPS in Lower Extremities Arteries
Status: Enrolling
Updated: 2/19/2018
Columbia-Presbyterian
mi
from
New York, NY
Click here to add this to my saved trials
Evaluation of WIRION™ EPS in Lower Extremities Arteries
Evaluation of WIRION™ EPS in Lower Extremities Arteries
Status: Enrolling
Updated:  2/19/2018
Denver VA Medical Center
mi
from
Denver, CO
Evaluation of WIRION™ EPS in Lower Extremities Arteries
Evaluation of WIRION™ EPS in Lower Extremities Arteries
Status: Enrolling
Updated: 2/19/2018
Denver VA Medical Center
mi
from
Denver, CO
Click here to add this to my saved trials
Evaluation of WIRION™ EPS in Lower Extremities Arteries
Evaluation of WIRION™ EPS in Lower Extremities Arteries
Status: Enrolling
Updated:  2/19/2018
St. Elizabeth Medical Center
mi
from
Boston, MA
Evaluation of WIRION™ EPS in Lower Extremities Arteries
Evaluation of WIRION™ EPS in Lower Extremities Arteries
Status: Enrolling
Updated: 2/19/2018
St. Elizabeth Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Evaluation of WIRION™ EPS in Lower Extremities Arteries
Evaluation of WIRION™ EPS in Lower Extremities Arteries
Status: Enrolling
Updated:  2/19/2018
St. John Hospital
mi
from
Detroit, MI
Evaluation of WIRION™ EPS in Lower Extremities Arteries
Evaluation of WIRION™ EPS in Lower Extremities Arteries
Status: Enrolling
Updated: 2/19/2018
St. John Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
Evaluation of WIRION™ EPS in Lower Extremities Arteries
Evaluation of WIRION™ EPS in Lower Extremities Arteries
Status: Enrolling
Updated:  2/19/2018
Lankenau Institute for Medical Research
mi
from
Philadelphia, PA
Evaluation of WIRION™ EPS in Lower Extremities Arteries
Evaluation of WIRION™ EPS in Lower Extremities Arteries
Status: Enrolling
Updated: 2/19/2018
Lankenau Institute for Medical Research
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Evaluation of WIRION™ EPS in Lower Extremities Arteries
Evaluation of WIRION™ EPS in Lower Extremities Arteries
Status: Enrolling
Updated:  2/19/2018
Miriam Hospital
mi
from
Providence, RI
Evaluation of WIRION™ EPS in Lower Extremities Arteries
Evaluation of WIRION™ EPS in Lower Extremities Arteries
Status: Enrolling
Updated: 2/19/2018
Miriam Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Evaluation of WIRION™ EPS in Lower Extremities Arteries
Evaluation of WIRION™ EPS in Lower Extremities Arteries
Status: Enrolling
Updated:  2/19/2018
Universitats herzzentrum Bad Krozingen
mi
from
Bad Krozingen,
Evaluation of WIRION™ EPS in Lower Extremities Arteries
Evaluation of WIRION™ EPS in Lower Extremities Arteries
Status: Enrolling
Updated: 2/19/2018
Universitats herzzentrum Bad Krozingen
mi
from
Bad Krozingen,
Click here to add this to my saved trials
Safety of Autologous Human Umbilical Cord Blood Treatment for Perinatal Arterial Ischemic Stroke
Safety of Autologous Human Umbilical Cord Blood Treatment for Perinatal
Status: Enrolling
Updated:  2/20/2018
Florida Hospital for Children
mi
from
Orlando, FL
Safety of Autologous Human Umbilical Cord Blood Treatment for Perinatal Arterial Ischemic Stroke
Safety of Autologous Human Umbilical Cord Blood Treatment for Perinatal
Status: Enrolling
Updated: 2/20/2018
Florida Hospital for Children
mi
from
Orlando, FL
Click here to add this to my saved trials
Functional Lesion Assessment of Intermediate Stenosis to Guide Revascularisation
Prospective, Multi-center, Double Blind, Randomised Study to Test the Safety of Deferral of Stenting in Physiological Non-significant Lesions in a Clinical Population of Intermediate Stenoses Using iFR and FFR
Status: Enrolling
Updated:  2/20/2018
Arnold Seto
mi
from
Long Beach, CA
Functional Lesion Assessment of Intermediate Stenosis to Guide Revascularisation
Prospective, Multi-center, Double Blind, Randomised Study to Test the Safety of Deferral of Stenting in Physiological Non-significant Lesions in a Clinical Population of Intermediate Stenoses Using iFR and FFR
Status: Enrolling
Updated: 2/20/2018
Arnold Seto
mi
from
Long Beach, CA
Click here to add this to my saved trials
Functional Lesion Assessment of Intermediate Stenosis to Guide Revascularisation
Prospective, Multi-center, Double Blind, Randomised Study to Test the Safety of Deferral of Stenting in Physiological Non-significant Lesions in a Clinical Population of Intermediate Stenoses Using iFR and FFR
Status: Enrolling
Updated:  2/20/2018
John Altman
mi
from
Lakewood, CO
Functional Lesion Assessment of Intermediate Stenosis to Guide Revascularisation
Prospective, Multi-center, Double Blind, Randomised Study to Test the Safety of Deferral of Stenting in Physiological Non-significant Lesions in a Clinical Population of Intermediate Stenoses Using iFR and FFR
Status: Enrolling
Updated: 2/20/2018
John Altman
mi
from
Lakewood, CO
Click here to add this to my saved trials
Functional Lesion Assessment of Intermediate Stenosis to Guide Revascularisation
Prospective, Multi-center, Double Blind, Randomised Study to Test the Safety of Deferral of Stenting in Physiological Non-significant Lesions in a Clinical Population of Intermediate Stenoses Using iFR and FFR
Status: Enrolling
Updated:  2/20/2018
Habib Samady
mi
from
Atlanta, GA
Functional Lesion Assessment of Intermediate Stenosis to Guide Revascularisation
Prospective, Multi-center, Double Blind, Randomised Study to Test the Safety of Deferral of Stenting in Physiological Non-significant Lesions in a Clinical Population of Intermediate Stenoses Using iFR and FFR
Status: Enrolling
Updated: 2/20/2018
Habib Samady
mi
from
Atlanta, GA
Click here to add this to my saved trials
Functional Lesion Assessment of Intermediate Stenosis to Guide Revascularisation
Prospective, Multi-center, Double Blind, Randomised Study to Test the Safety of Deferral of Stenting in Physiological Non-significant Lesions in a Clinical Population of Intermediate Stenoses Using iFR and FFR
Status: Enrolling
Updated:  2/20/2018
Allen Jeremias
mi
from
Stony Brook, NY
Functional Lesion Assessment of Intermediate Stenosis to Guide Revascularisation
Prospective, Multi-center, Double Blind, Randomised Study to Test the Safety of Deferral of Stenting in Physiological Non-significant Lesions in a Clinical Population of Intermediate Stenoses Using iFR and FFR
Status: Enrolling
Updated: 2/20/2018
Allen Jeremias
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Functional Lesion Assessment of Intermediate Stenosis to Guide Revascularisation
Prospective, Multi-center, Double Blind, Randomised Study to Test the Safety of Deferral of Stenting in Physiological Non-significant Lesions in a Clinical Population of Intermediate Stenoses Using iFR and FFR
Status: Enrolling
Updated:  2/20/2018
Manesh Patel
mi
from
Durham, NC
Functional Lesion Assessment of Intermediate Stenosis to Guide Revascularisation
Prospective, Multi-center, Double Blind, Randomised Study to Test the Safety of Deferral of Stenting in Physiological Non-significant Lesions in a Clinical Population of Intermediate Stenoses Using iFR and FFR
Status: Enrolling
Updated: 2/20/2018
Manesh Patel
mi
from
Durham, NC
Click here to add this to my saved trials
Functional Lesion Assessment of Intermediate Stenosis to Guide Revascularisation
Prospective, Multi-center, Double Blind, Randomised Study to Test the Safety of Deferral of Stenting in Physiological Non-significant Lesions in a Clinical Population of Intermediate Stenoses Using iFR and FFR
Status: Enrolling
Updated:  2/20/2018
Sam Lehman
mi
from
Adelaide,
Functional Lesion Assessment of Intermediate Stenosis to Guide Revascularisation
Prospective, Multi-center, Double Blind, Randomised Study to Test the Safety of Deferral of Stenting in Physiological Non-significant Lesions in a Clinical Population of Intermediate Stenoses Using iFR and FFR
Status: Enrolling
Updated: 2/20/2018
Sam Lehman
mi
from
Adelaide,
Click here to add this to my saved trials
Functional Lesion Assessment of Intermediate Stenosis to Guide Revascularisation
Prospective, Multi-center, Double Blind, Randomised Study to Test the Safety of Deferral of Stenting in Physiological Non-significant Lesions in a Clinical Population of Intermediate Stenoses Using iFR and FFR
Status: Enrolling
Updated:  2/20/2018
Washington University School of Medicine
mi
from
Saint Louis, MO
Functional Lesion Assessment of Intermediate Stenosis to Guide Revascularisation
Prospective, Multi-center, Double Blind, Randomised Study to Test the Safety of Deferral of Stenting in Physiological Non-significant Lesions in a Clinical Population of Intermediate Stenoses Using iFR and FFR
Status: Enrolling
Updated: 2/20/2018
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
A Multicenter, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study of Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
Status: Enrolling
Updated:  2/20/2018
Brookwood Medical Center
mi
from
Birmingham, AL
Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
A Multicenter, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study of Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
Status: Enrolling
Updated: 2/20/2018
Brookwood Medical Center
mi
from
Birmingham, AL
Click here to add this to my saved trials
Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
A Multicenter, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study of Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
Status: Enrolling
Updated:  2/20/2018
Baptist Medical Center - Princeton
mi
from
Birmingham, AL
Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
A Multicenter, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study of Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
Status: Enrolling
Updated: 2/20/2018
Baptist Medical Center - Princeton
mi
from
Birmingham, AL
Click here to add this to my saved trials
Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
A Multicenter, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study of Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
Status: Enrolling
Updated:  2/20/2018
Baptist Health Systems Montclair
mi
from
Birmingham, AL
Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
A Multicenter, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study of Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
Status: Enrolling
Updated: 2/20/2018
Baptist Health Systems Montclair
mi
from
Birmingham, AL
Click here to add this to my saved trials
Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
A Multicenter, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study of Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
Status: Enrolling
Updated:  2/20/2018
Medical Center East Hospital
mi
from
Birmingham, AL
Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
A Multicenter, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study of Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
Status: Enrolling
Updated: 2/20/2018
Medical Center East Hospital
mi
from
Birmingham, AL
Click here to add this to my saved trials
Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
A Multicenter, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study of Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
Status: Enrolling
Updated:  2/20/2018
University Of Alabama At Birmingham Hospital
mi
from
Birmingham, AL
Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
A Multicenter, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study of Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
Status: Enrolling
Updated: 2/20/2018
University Of Alabama At Birmingham Hospital
mi
from
Birmingham, AL
Click here to add this to my saved trials
Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
A Multicenter, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study of Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
Status: Enrolling
Updated:  2/20/2018
Thomas Hospital
mi
from
Fairhope, AL
Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
A Multicenter, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study of Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
Status: Enrolling
Updated: 2/20/2018
Thomas Hospital
mi
from
Fairhope, AL
Click here to add this to my saved trials
Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
A Multicenter, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study of Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
Status: Enrolling
Updated:  2/20/2018
Huntsville Hospital
mi
from
Huntsville, AL
Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
A Multicenter, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study of Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
Status: Enrolling
Updated: 2/20/2018
Huntsville Hospital
mi
from
Huntsville, AL
Click here to add this to my saved trials
Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
A Multicenter, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study of Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
Status: Enrolling
Updated:  2/20/2018
Mobile Infirmary Medical Center
mi
from
Mobile, AL
Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
A Multicenter, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study of Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
Status: Enrolling
Updated: 2/20/2018
Mobile Infirmary Medical Center
mi
from
Mobile, AL
Click here to add this to my saved trials
Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
A Multicenter, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study of Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
Status: Enrolling
Updated:  2/20/2018
Banner Good Samaritan Medical Center
mi
from
Phoenix, AZ
Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
A Multicenter, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study of Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
Status: Enrolling
Updated: 2/20/2018
Banner Good Samaritan Medical Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
A Multicenter, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study of Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
Status: Enrolling
Updated:  2/20/2018
Arizona Health Sciences Center
mi
from
Tucson, AZ
Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
A Multicenter, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study of Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
Status: Enrolling
Updated: 2/20/2018
Arizona Health Sciences Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
A Multicenter, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study of Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
Status: Enrolling
Updated:  2/20/2018
Southern Arizona Veterans Affairs Health Care System
mi
from
Tucson, AZ
Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
A Multicenter, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study of Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
Status: Enrolling
Updated: 2/20/2018
Southern Arizona Veterans Affairs Health Care System
mi
from
Tucson, AZ
Click here to add this to my saved trials
Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
A Multicenter, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study of Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
Status: Enrolling
Updated:  2/20/2018
Sparks Regional Medical Center
mi
from
Fort Smith, AR
Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
A Multicenter, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study of Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
Status: Enrolling
Updated: 2/20/2018
Sparks Regional Medical Center
mi
from
Fort Smith, AR
Click here to add this to my saved trials
Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
A Multicenter, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study of Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
Status: Enrolling
Updated:  2/20/2018
Baptist Medical Center
mi
from
Little Rock, AR
Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
A Multicenter, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study of Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
Status: Enrolling
Updated: 2/20/2018
Baptist Medical Center
mi
from
Little Rock, AR
Click here to add this to my saved trials
Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
A Multicenter, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study of Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
Status: Enrolling
Updated:  2/20/2018
Bakersfield Heart Hospital
mi
from
Bakersfield, CA
Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
A Multicenter, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study of Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
Status: Enrolling
Updated: 2/20/2018
Bakersfield Heart Hospital
mi
from
Bakersfield, CA
Click here to add this to my saved trials
Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
A Multicenter, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study of Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
Status: Enrolling
Updated:  2/20/2018
Seaton Medical Center
mi
from
Daly City, CA
Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
A Multicenter, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study of Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
Status: Enrolling
Updated: 2/20/2018
Seaton Medical Center
mi
from
Daly City, CA
Click here to add this to my saved trials
Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
A Multicenter, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study of Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
Status: Enrolling
Updated:  2/20/2018
Palomar Medical Center
mi
from
Escondido, CA
Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
A Multicenter, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study of Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
Status: Enrolling
Updated: 2/20/2018
Palomar Medical Center
mi
from
Escondido, CA
Click here to add this to my saved trials
Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
A Multicenter, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study of Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
Status: Enrolling
Updated:  2/20/2018
Saddleback Memorial Medical Center
mi
from
Laguna Hills, CA
Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
A Multicenter, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study of Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
Status: Enrolling
Updated: 2/20/2018
Saddleback Memorial Medical Center
mi
from
Laguna Hills, CA
Click here to add this to my saved trials
Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
A Multicenter, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study of Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
Status: Enrolling
Updated:  2/20/2018
Los Angeles County/University of Southern California Medical Center
mi
from
Los Angeles, CA
Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
A Multicenter, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study of Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
Status: Enrolling
Updated: 2/20/2018
Los Angeles County/University of Southern California Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
A Multicenter, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study of Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
Status: Enrolling
Updated:  2/20/2018
University of Southern California University Hospital
mi
from
Los Angeles, CA
Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
A Multicenter, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study of Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
Status: Enrolling
Updated: 2/20/2018
University of Southern California University Hospital
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
A Multicenter, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study of Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
Status: Enrolling
Updated:  2/20/2018
St. Vincent Medical Center
mi
from
Los Angeles, CA
Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
A Multicenter, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study of Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
Status: Enrolling
Updated: 2/20/2018
St. Vincent Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
A Multicenter, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study of Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
Status: Enrolling
Updated:  2/20/2018
Veterans Administration Greater Los Angeles Healthcare Sysytem
mi
from
Los Angeles, CA
Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
A Multicenter, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study of Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)
Status: Enrolling
Updated: 2/20/2018
Veterans Administration Greater Los Angeles Healthcare Sysytem
mi
from
Los Angeles, CA
Click here to add this to my saved trials